Editorial commentary: The lower the LDL the better but how and how much?-Reference-Cited by-同舟云学术

Editorial commentary: The lower the LDL the better but how and how much?

Published:2018-07 Issue:5 Volume:28 Page:355-356
ISSN:1050-1738
Container-title:Trends in Cardiovascular Medicine
language:en
Short-container-title:Trends in Cardiovascular Medicine

Author:

Gitin Alexander,Pfeffer Marc A.,Hennekens Charles H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference6 articles.

1. LDL lowering: how low to go?;Packard;Trends Cardiovasc Med,2018

2. Increasing global burden of cardiovascular disease; current knowledge and future directions for research on risk factors;Hennekens;Special report of the Conner Lecture at the American Heart Association Circulation,1998

3. Statins in the treatment and prevention of cardiovascular diseases: current and emerging clinical and public health challenges;Hennekens,2016

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials;Lancet,2010

5. Interpretation of the evidence for the efficacy and safety of statin therapy;Collins;Lancet,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium Outflow;Reviews in Cardiovascular Medicine;2022-07-22

2. Editorial commentary: Icosapent ethyl in the treatment and prevention of cardiovascular disease;Trends in Cardiovascular Medicine;2020-04

3. Lower LDL is better – can this be achieved with CETP inhibition therapy?;Expert Review of Cardiovascular Therapy;2020-01-02

4. Prescription of Aspirin and Statins in Primary Prevention;Primary Care: Clinics in Office Practice;2019-03